Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Tai Chi Therapy Versus Qi-Gong in Stage-I Parkinson's Patients.

25. august 2026 oppdatert av: Lahore University of Biological and Applied Sciences

Effects of Tai Chi Therapy Versus Qi-Gong on Postural Control, Functional Balance , and Motor Function in Stage-I Parkinson's Patients.

This study has important clinical, academic, and practical relevance in neuromuscular rehabilitation. Clinically, it aims to identify effective and tolerable rehabilitation strategies for individuals with Parkinson's disease by comparing Tai Chi Therapy with Qi-Gong there by supporting evidence-based physiotherapy practice and improving patient adherence. Academically, it contributes to the limited literature on comparative effectiveness of these interventions and incorporates patient-centered outcomes such as exercise perception, which are often underreported. From a practical and societal perspective, identifying a more acceptable and effective approach may enhance long-term participation in rehabilitation, potentially slow disease progression, and reduce the overall healthcare burden associated with Parkinson's disease.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Parkinson's disease is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra, leading to motor symptoms such as tremor, rigidity, bradykinesia, and postural instability. The title of the present study focuses on evaluating the effectiveness of Tai Chi Therapy versus Qi-Gong on Postural Control, Functional Balance and Motor Function in individuals with Stage-I with Parkinson's disease. The study design is a randomized controlled trial with participants allocated into two groups. The study duration is expected to span 8 to 12 weeks, allowing sufficient time for neuromuscular adaptations and observable functional improvements while maintaining feasibility and participant compliance. Outcome measures include standardized and validated tools such as the Unified Parkinson's Disease Rating Scale for assessing disease severity, the Berge Balance Scale is use for the functional balance and postural control these measures are recorded at baseline and post-intervention to determine the effectiveness of the rehabilitation protocol, providing comprehensive insight into motor Motor Control, Functional Balance and Motor Function in individuals with Stage I Parkinson's disease.

Studietype

Intervensjonell

Registrering (Antatt)

50

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

  • Navn: Salwa Atta
  • Telefonnummer: 03084579229

Studiesteder

  • Pakistan
      • Lahore, Pakistan
        • Rekruttering
        • The Meer's Physiotherapy and Rehabilitation
        • Ta kontakt med:
    • Punjab Province
      • Lahore, Punjab Province, Pakistan
        • Rekruttering
        • Ghurki Trust and Teaching Hospital
        • Ta kontakt med:
          • Dr. Mir Shakeel Ahmad

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Diagnosis of PD based on the Hoehn & Yahr staging system (Stages I).
  • Male or female patients aged between 50-65 years.
  • Currently receiving stable anti-Parkinsonian medication, with no changes in the treatment regimen for at least 3 months.
  • Basic self-care ability with no severe cognitive impairment (Mini-Mental State Examination [MMSE] score ≥24).

Exclusion Criteria:

  • Depression, as assessed based on a score of >16 for the Beck Depression Inventory-II (BDI-II).
  • Recent deep brain stimulation (DBS) treatment.
  • Use of medication that interferes with cognition, alertness, or attention.
  • Current participation in an exercise training program.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Tai Chi
Tai Chi is a traditional Chinese "moving meditation" that combines slow, gentle movements with deep diaphragmatic breathing and focused attention. It is designed to cultivate inner energy and harmonize mind and body, making it a popular low-impact, therapeutic exercise.
Annen: Tai Chi
Group A will receive 8 weeks of standard conventional physical therapy plus Tai Chi (40 min of Tai Chi and 20 min of conventional physical therapy) total duration of session will be 60 minutes. The most commonly applied Tai Chi style will be Yang style.
Eksperimentell: Qi Gong
It is a holistic, low-impact mind-body practice that combines slow, flowing movements, deep rhythmic breathing, and focused intention to balance energy flow, improve health, and enhance overall vitality.
Annen: Qi Gong
Group B will receive 8 weeks of standard conventional physical therapy (20 minutes) plus Health Qigong Baduanjin and wuqinxi ( 40 minutes) with total duration of 60 minutes, 2 times a week each pattern for 8 weeks.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Unified Parkinson's Disease Rating Scale
Tidsramme: 8-12 weeks
It will be used for motor function. UPDRS shows high ICCs like 0.90 for Motor, 0.85 for ADL).A higher score indicates greater motor impairment and disease severity. Total score is 108 across 27 items. It will be used at pre and post intervention.
8-12 weeks
Berg Balance Scale (BBS)
Tidsramme: 8-12 weeks
The Berg Balance Scale (BBS) is a widely used clinical test with 14 functional tasks (like sitting, standing, reaching, turning) to measure static and dynamic postural control and functional balance, primarily to assess fall risk in older adults and neurological patients (stroke, Parkinson's). It scores tasks from 0 (unable) to 4 (independent) for a total of 56, with lower scores indicating higher fall risk, helping therapists plan interventions. It Shows very high intra-rater (same tester) and inter-rater (different testers) reliability, with Intraclass Correlation Coefficients (ICC) often around 0.97-0.99. The Berg Balance Scale have 14-item. Each item is scored on a 0-4 scale, with a total score of 56 points indicating no balance deficit and lower scores correlating with higher fall risk. The patients with the scores between 0-20 have High fall risk (may need wheelchair), 21-40: Medium fall risk (may need cane/walker) and 41-56: Low fall risk (independent mobility).
8-12 weeks

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Lahore University of Biological and Applied Sciences

Etterforskere

  • Studieleder: Salwa Atta, Lahore University of Biological & Applied Sciences

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

30. mai 2026

Primær fullføring (Antatt)

30. august 2026

Studiet fullført (Antatt)

10. oktober 2026

Datoer for studieregistrering

Først innsendt

17. juni 2026

Først innsendt som oppfylte QC-kriteriene

17. juni 2026

Først lagt ut (Faktiske)

23. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

26. august 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

25. august 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • UBAS/ERB/26/4/039

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere